Cell Cycle Analysis Market Research Report - Global Forecast to 2021

Cell Cycle Analysis Market Research Report - Global Forecast to 2021

ID: MRFR/LS/0202-HCRR | August, 2018 | Region: Global | 140 pages | Half-Cooked Research Reports

Cell Cycle Analysis Market Research Report, By Product (Software, Kits, Microscope, Instruments), Method (Flow Cytometry, HCS), Application (Research, Diagnosis), End User (CRO, Hospital, Biotechnology, Pharmaceutical, Academic)- Global Forecast to 2021


Cell cycle analysis is commonly used in biomedical research studies and clinical diagnosis. It helps in distinguishing cells that are in different phases ofcell cycle and used to determine the cellular response to biological stimulations and various drug. Cell cycle analysis traditionally carried out though the sensitive fluorescence detection methods such as flow cytometry and laser scanning cytometry.


The cell cycle analysis market is expected to grow at high growth rate due to corporate & government support in cell-based researches, high prevalence of chronic genetic diseases, growing healthcare industry and increasing medical spending, rising incidence of cancer, and technologically advancements. However, high prices of automated cell cycle analysis instruments, and reluctance among researchers to use advanced cell cycle analysis techniques may restrict the growth of this market. Furthermore, theinstruments used in cell cycle analysis are relatively expensive, and large in size. It also requires a considerable amount of maintenance, which is less likely to be feasible for small research groups.Hence it is difficult for the small research group to access to this equipment when required quick diagnostic results on site. Also, reluctance among researchers to use advanced cell cycle analysis techniques is another growth barrier for the market.


The cell cycle analysisisperformedthroughmethods such as cytometry, cell imaging, cell counting, Microscopy, and others. Majority of these methods are based on florescence assays. Among these methods cytometry methods are expected to command the highest market share in 2015. The prominent players in cell cycle analysis market are Becton, Dickinson and Company, Merck KGAA, Thermo Fisher Scientific, Inc., Danaher Corporation, GE Healthcare, Agilent Technologies, Inc., Olympus Corporation, PerkinElmer, Inc., Promega Corporation, Affymetrix, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotech, and Nexcelom Bioscience LLC.These players possess state of art manufacturing facilities and strong sales and distribution network which have helped them to gain leadership position in the market


Based on the method the cell cycle analysis by product is divided into instruments, consumables, software and others. Consumables market is further segmented into assay, reagents & kits and other consumables. There is an incessant rise in the number of genetic disease worldwide which is expected to drive the growth of this market.


`Furthermore, based on the applications the cell cycle analysis market is segmented into diagnosis, therapeutics, research, and others. The research segment is expected to grow at highest CAGR due to rising government and corporate support for cell based research.


Based on End users the cell cycle analysis market is further divided into Academics & Research Institutions, Hospitals and Diagnostic Laboratories, Pharmaceutical- CROs and Biotechnology Companies, and Other End Users. The rising incidences of cancer and genetic diseaseare expected to drive end users market for global cell analysis market.


Based on region, North America accounted for the largest share in the global cell cycle analysis market, followed by Europe and Asia Pacific. The Asia Pacific market is expected to witness the highest growth owing to rising awareness regarding self-monitoring. Furthermore, various players are investing in the Asia Pacific market which is another major factor fueling the market growth.


The cell cycle analysis market research report provides detail analysis of market in terms of value market. The report also provides the future outlook of the market till 2021. Moreover, the global as well as market share of various players based on methods is also analyzed in the report. Lastly, the report provides company profiles of major players in the market.


Scope of the Report


This market research report covers the global cell cycle analysis market by product / methods, application, end user, and region.


Global Cell Cycle Analysis Market, by Products / Method



  • Introduction

  • Cytometry

  • Flow Cytometry

  • Instruments

  • Consumables

  • Assay

  • Reagents & Kits

  • Other Consumables

  • Software

  • Image Cytometry

  • Instruments

  • Consumables

  • Assay

  • Reagents & Kits

  • Other Consumables

  • Cell Imaging & Cell Counting

  • Instruments

  • High Content Screening (HCS)

  • Automated Cell Counter

  • Consumables

  • Assay

  • Reagents & Kits           

  • Other Consumables

  • Microscopy

  • Instruments

  • Consumables

  • Assay

  • Reagents & Kits           

  • Other Consumables

  • Others


Global Cell Cycle Analysis Market, by Applications




  • Introduction

  • Diagnosis

  • Therapeutics

  • Research

  • Others



Global Cell Cycle Analysis Market, by End Users




  • Introduction

  • Academics & Research Institutions

  • Hospitals and Diagnostic Laboratories

  • Pharmaceutical- CROs and Biotechnology Companies

  • Other End Users



Global Cell Cycle Analysis Market, by Region




  • Introduction

  • North America

  • U.S.

  • Canada

  • Europe

  • Germany

  • France

  • U.K.

  • Italy

  • Spain

  • Rest of Europe

  • Asia     

  • Japan

  • China

  • India

  • Rest of Asia

  • Rest of the World


License
Single User Enterprise User (Buy Premium Reports Chapterwise)
Currency
TABLE OF CONTENTS

1.1 Definition


1.2 Scope of the study


1.2.1 Research Objectives


1.2.2 Assumptions & Limitations


1.3 Market Structure

2.1 Research Process


2.2 Primary Research


2.3 Secondary Research


2.4 Forecast Model

4.1 Introduction


4.2 Growth Drivers


4.2.1 Corporate & Government support in Cell-Based Researches


4.2.2 High prevalence of Chronic genetically Diseases


4.2.3 Growing Healthcare Industry & Increasing Medical Spending


4.2.4 Rising Incidence of Cancer


4.2.5 Technologically Advancements


4.3 Growth Barriers


4.3.1 High prices of automated Cell cycle Analysis instruments


4.3.2 Reluctance Among Researchers to Use Advanced Cell cycle analysis Techniques


4.4 Market Opportunities


4.4.1 Growing APAC Market


4.4.2 Rising Stem Cell Research


4.4.3 Rising Cancer Researches


4.5 Macroecnomical Indicators

5.1 Marketing Mix


5.2 Porter's Five Force


5.3 Supply Chain Analysis


5.4 Value chain Analysis

6.1 Introduction


6.2 Cytometry


6.2.1 Flow Cytometry








6.2.2 Image Cytometry







6.3 Cell Imaging & Cell Counting


6.3.1 Instruments




6.3.2 Consumables





6.4 Microscopy


6.4..1 Instruments


6.4.2 Consumables





6.5 Others

7.1 Introduction


7.2 Diagnosis


7.3 Therapeutics


7.4 Research


7.5 Others

8.1 Introduction


8.2 Academics & Research Institutions


8.3 Hospitals and Diagnostic Laboratories


8.4 Pharmaceutical- CROs and Biotechnology Companies


8.5 Other End Users

9.1 Introduction


9.2 North America


9.2.1 U.S.


9.2.2 Canada


9.3 Europe


9.3.1 Germany


9.3.2 France


9.3.3 U.K.


9.3.4 Italy


9.3.5 Spain


9.3.6 Rest of Europe


9.4 Asia


9.4.1 Japan


9.4.2 China


9.4.3 India


9.4.4 Rest of Asia


9.5 Rest of the World

10.1 Introduction


10.2 Market Share Analysis


10.3 Competitive/Strategic Scenario


10.3.1 Mergers Acquisitions


10.3.2 Collaborations


10.3.3 Expansion


10.3.4 New Product Launches

11.1 Introduction


11.2 Becton, Dickinson and Company


11.2.1 Overview


11.2.2 Financials


11.2.3 Product Portfolio


11.2.4 Recent Developments


11.2.5 Business Strategies


11.3 Merck KGAA


11.3.1 Overview


11.3.2 Financials


11.3.3 Product Portfolio


11.3.4 Recent Developments


11.3.5 Business Strategies


11.4 Thermo Fisher Scientific, Inc.


11.4.1 Overview


11.4.2 Financials


11.4.3 Product Portfolio


11.4.4 Recent Developments


11.4.5 Business Strategies


11.5 Danaher Corporation


11.5.1 Overview


11.5.2 Financials


11.5.3 Product Portfolio


11.5.4 Recent Developments


11.5.5 Business Strategies


11.6 GE Healthcare


11.6.1 Overview


11.6.2 Financials


11.6.3 Product Portfolio


11.6.4 Recent Developments


11.6.5 Business Strategies


11.7 Olympus Corporation


11.7.1 Overview


11.7.2 Financials


11.7.3 Product Portfolio


11.7.4 Recent Developments


11.7.5 Business Strategies


11.8 PerkinElmer, Inc.


11.8.1 Overview


11.8.2 Financials


11.8.3 Product Portfolio


11.8.4 Recent Developments


11.8.5 Business Strategies


11.9 Promega Corporation


11.9.1 Overview


11.9.2 Financials


11.9.3 Product Portfolio


11.9.4 Recent Developments


11.9.5 Business Strategies


11.10 Affymetrix, Inc.


11.10.1 Overview


11.10.2 Financials


11.10.3 Product Portfolio


11.10.4 Recent Developments


11.10.5 Business Strategies


11.11 Bio-Rad Laboratories, Inc.


11.11.1 Overview


11.11.2 Financials


11.11.3 Product Portfolio


11.11.4 Recent Developments


11.11.5 Business Strategies


11.12 Agilent Technologies, Inc.


11.12.1 Overview


11.12.2 Financials


11.12.3 Product Portfolio


11.12.4 Recent Developments


11.12.5 Business Strategies


11.13 Miltenyi Biotech


11.13.1 Overview


11.13.2 Financials


11.13.3 Product Portfolio


11.13.4 Recent Developments


11.13.5 Business Strategies


11.14 Nexcelom Bioscience LLC


11.14.1 Overview


11.14.2 Financials


11.14.3 Product Portfolio


11.14.4 Recent Developments


11.14.5 Business Strategies

12.1 Discussion Blue Print


12.2 Industry Expert Quotes


12.3 Bibliography